Allianz Asset Management
IDIX

Allianz Asset Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Allianz Asset Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-340,000
Closed -$8.2M – 2436
2014
Q2 		$8.2M Buy
340,000
+315,000
+1,260% +$3.28M 0.01% 794
2014
Q1 		$151K Sell
25,000
-10,000
-29% -$69.7K ﹤0.01% 1810
2013
Q4 		$209K Buy
35,000
+11,000
+46% +$50.9K ﹤0.01% 1703
2013
Q3 		$125K Hold
24,000
– – ﹤0.01% 1710
2013
Q2 		$87K Buy
+24,000
New +$98.2K ﹤0.01% 1688

Allianz Asset Management's IDIX Position: Q3 2014 in Review

Allianz Asset Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 340,000 shares — an estimated $8.2M sold.

Allianz Asset Management first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $8.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Allianz Asset Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Allianz Asset Management sold 340,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $8.2M.
  • Allianz Asset Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Allianz Asset Management's IDENIX PHARMACEUTICALS INC position peaked at $8.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Allianz Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.